North American Prodromal Synucleinopathy Consortium
Sponsor:
Washington University School of Medicine
Brief Summary:
This study will enroll participants with idiopathic rapid eye movement (REM) sleep behavior
disorder (RBD), for the purpose of preparing for a clinical trial of neuroprotective
treatments against synucleinopathies.
disorder (RBD), for the purpose of preparing for a clinical trial of neuroprotective
treatments against synucleinopathies.
Criteria
Inclusion Criteria:
– Idiopathic REM sleep behavior disorder
Exclusion Criteria:
– REM sleep behavior disorder secondary to another cause (ex: narcolepsy, dementia,
Parkinson’s Disease, etc)
– Other neurological disorder
Locations
- University of California Los Angeles, Los Angeles, California, United States, 90095
- Stanford University, Redwood City, California, United States, 94063
